Final results for DiaGenic ASA's subsequent offering

Reference is made the stock exchange notice dated 9 February 2010. According to the final results of DiaGenic ASA’s ("DiaGenic") subsequent offering, where the subscription period ended 8 February 2010 at 17:30 (CET), DiaGenic has received subscriptions for 7,826,413 new shares. Thus, the subsequent offering was oversubscribed by 124 per cent. 2,654,569 new shares, equivalent to 76 per cent of the offered shares, were subscribed for with subscription rights. The new shares are allocated pursuant to the principles outlined in the prospectus published on 21 January 2010. Notifications of allocated new shares in the subsequent offering and the corresponding amount to be paid by each subscriber, will be mailed to the subscribers today. The subscribers who are allocated shares will receive one warrant per share allocated, pursuant to the resolution at the extraordinary general meeting on 18 December 2009. Through the subsequent offering DiaGenic will receive a gross proceed of approximately NOK 9.6 million before transaction costs. DiaGenic’s share capital after the completed subsequent offering is NOK 3,511,826, divided into 70,236,520 shares, each with a nominal value of NOK 0.05. The new shares will be listed on Oslo Børs as soon as the share capital increase has been registered with the Norwegian Register of Business Enterprises and the new shares have been registered with the Norwegian Central Securities Depository (VPS). The new shares are expected to be listed on or about 23 February 2010. The subscribers may not trade the new shares until they have been paid for and registered on each subscriber's VPS account. Argo Securities AS and Orion Securities AS have acted as managers in the subsequent offering. For further information, please contact: Håkon Sæterøy (chairman of the board), telephone +47 92 69 51 75 This information is subject of disclosure requirement according to section 5-12 of the Norwegian Securities Trading Act.